Cannabinoids, Psychosis, Neural Synchrony, and Information Processing

Completed Early Phase 1 NCT00708994

Study Description

The study examines the effects of delta-9-tetrahydrocannabinol (Δ9-THC), the principal active ingredient of cannabis, on neural synchrony. Neural synchrony is studied using electroencephalography (EEG).

Study Details

Registry ID:: NCT00708994
Conditions:: Cannabis, Psychotic Disorders
Phase:: Early Phase 1
Target Enrollment:: 42 participants
Start Date:: February 25, 2008
Healthy Volunteers:: No

Study Locations (1 site)

VA Connecticut Healthcare System
West Haven, ConnecticutUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →